AAPS PharmSciTech 2010-09-01

Enhancement of bioavailability of cefpodoxime proxetil using different polymeric microparticles.

Fahim Khan, Rajesh Katara, Suman Ramteke

Index: AAPS PharmSciTech 11(3) , 1368-75, (2010)

Full Text: HTML

Abstract

Poorly water-soluble drugs such as cefpodoxime proxetil (400 μg/ml) offer a challenging problem in drug formulation as poor solubility is generally associated with poor dissolution characteristics and thus poor oral bioavailability. According to these characteristics, preparation of cefpodoxime proxetil microparticle has been achieved using high-speed homogenization. Polymers (methylcellulose, sodium alginate, and chitosan) were precipitated on the surface of cefpodoxime proxetil using sodium citrate and calcium chloride as salting-out agents. The pure drug and the prepared microparticles with different concentrations of polymer (0.05-1.0%) were characterized in terms of solubility, drug content, particle size, thermal behavior (differential scanning calorimeter), surface morphology (scanning electron microscopy), in vitro drug release, and stability studies. The in vivo performance was assessed by pharmacokinetic study. The dissolution studies demonstrate a marked increase in the dissolution rate in comparison with pure drug. The considerable improvement in the dissolution rate of cefpodoxime proxetil from optimized microparticle was attributed to the wetting effect of polymers, altered surface morphology, and micronization of drug particles. The optimized microparticles exhibited excellent stability on storage at accelerated condition. The in vivo studies revealed that the optimized formulations provided improved pharmacokinetic parameter in rats as compared with pure drug. The particle size of drug was drastically reduced during formulation process of microparticles.


Related Compounds

  • Cefpodoxime Proxe...

Related Articles:

A multicentric, open label, randomised, postmarketing efficacy study comparing multidose of lincomycin hydrochloride capsule 500 mg with multidose cefpodoxime proxetil tablet 200 mg in patients with tonsillitis, sinusitis.

2012-08-01

[J. Indian Med. Assoc. 110(8) , 580-3, (2012)]

Ionic liquids as superior solvents for headspace gas chromatography of residual solvents with very low vapor pressure, relevant for pharmaceutical final dosage forms.

2009-08-07

[J. Chromatogr. A. 1216(32) , 6020-3, (2009)]

Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infections.

1996-08-01

[Pharmacoeconomics 10(2) , 164-78, (1996)]

An efficient one-pot reaction for selective fluorimetric determination of cefpodoxime and its prodrug.

2011-09-30

[Talanta 85(4) , 2121-7, (2011)]

Simultaneous quantification of cefpodoxime proxetil and clavulanic acid in human plasma by LC-MS using solid phase extraction with application to pharmacokinetic studies.

2013-03-15

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 921-922 , 49-55, (2013)]

More Articles...